Redeye is only making minor changes to our forecasts following the Q2 report and other recent events. Insplorion’s collaboration with Consilium is making progress with a new large order around the corner and ATEX certification is expected by Q4. Moreover, the announced directed share issue of SEK6m is welcome, but further funding will be needed, probably before year-end.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/